- Activity pressure is positive on the latest completed week.
JDG
LSE
Week ended 07 Aug 2026
Weekly Investor Report
Judges Scientific plc · Technology · Scientific & Technical Instruments
Latest close
4,250 GBP
-7.0%
latest week
Weekly setup
Weak trend
The weekly trend is not active. Price is -7.8% below the Trend Line and sits at 21.9% of its 52-week range. The latest completed week returned -7.0%, after a -12.4% four-week move. The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks weakly; valuation is expensive relative to peers. The latest news-sentiment score is 50/100. Near-term considerations: volume confirmation is below normal.
Setup score
23
out of 100
Latest Close
4,250 GBP
7 Aug 2026
1W Return
-7.0%
latest completed week
4W Return
-12.4%
short-term follow-through
12W Return
-16.0%
quarterly tape
Trend Breadth
0.0%
0 of 52 weeks active
Volume Ratio
0.8x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Activity pressure is weak, so confirmation is not yet broad enough.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-7.0%
Latest completed week; four-week move -12.4%.
Indicator stack
0/57
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Recent
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
50/100
11 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -7.8% below the Trend Line and sits at 21.9% of its 52-week range. The latest completed week returned -7.0%, after a -12.4% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.8x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.1812-week average 0.22
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.18Current proprietary activity-pressure read.
Buy signals2Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -12.4% over four weeks, -16.0% over 12 weeks, and -28.7% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year0
Trend breadth0.0%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.50Latest activity-pressure read.
Pressure change-27.4%Four-week change in activity pressure.
Leadership-24.23Latest relative-leadership reading.
RS change-69.3%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks weakly; valuation is expensive relative to peers.
Factor week 09 Aug 2026
Financial statements through 31 Dec 2025
Field coverage 91%
Model confidence 72%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength15/100Blend of value, momentum, and quality. Underlying universe rank 86; rank 1 is best.
Value7/100Relative valuation strength. Underlying universe rank 94; rank 1 is best.
Quality93/100Profitability and accounting quality. Underlying universe rank 8; rank 1 is best.
Momentum5/100Medium-term price momentum. Underlying universe rank 96; rank 1 is best.
Growth12/100Revenue and earnings growth. Underlying universe rank 89; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Value-quality framework18/100Value and quality alignment from the Sharemaestro SVQF framework.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- 51.5x Price divided by trailing earnings.
- Price / sales
- 1.9x Market value relative to trailing revenue.
- EV / EBITDA
- 10.1x Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- 6.8% Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- 69.3% Gross profit retained from each unit of revenue.
- Operating margin
- 8.8% Operating profit retained from revenue.
- Free-cash-flow margin
- 15.4% Free cash flow generated from revenue.
- Return on invested capital
- 7.4% Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- 9.1% Latest one-year revenue growth.
- EPS growth
- -47.2% Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- 1.4% Latest one-year free-cash-flow growth.
- Piotroski F-score
- 7/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- 2.7% Cash dividends relative to market value.
- Buyback yield
- -0.0% Net share repurchases relative to market value.
- Shareholder yield
- 2.7% Dividend yield plus net buyback yield.
- Net debt / EBITDA
- 1.4x Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 11 relevant articles.
0 positive · 9 neutral · 2 negativePatient CapitalRecent
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
Recent buy signal in the last 8 weeks
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-39.3%Distance below the 52-week high.
13-week volatility4.7%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher15 of 2611 weeks finished lower.
Best week+9.3%Week of 27 Mar.
Worst week-12.9%Week of 6 Mar.
Latest week-7.0%Week of 7 Aug.
Shape of recent returns
Strong gains3
Modest gains12
Flat weeks0
Modest losses4
Sharp losses7
Recent vol4.7%13-week weekly-return volatility.
Base vol6.2%52-week weekly-return volatility.
Up/down split28/24Count of positive and negative weeks in the 52-week window.
Average skew3.9% / -5.6%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorGB Technology
4-week rank90 / 100
Group average2.8%
Trend breadth37.0%
Trend37.0%active weekly trend signals
MD58.0%positive activity pressure
RS34.0%positive relative leadership
Four-week leaders
IndustryGB Scientific & Technical Instruments
4-week rank10 / 11
Group average1.4%
Trend breadth45.5%
Trend45.5%active weekly trend signals
MD36.4%positive activity pressure
RS45.5%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape24/100
Trend, activity pressure, participation, and risk combine to a 24/100 tape read.
Indicator analysis33/100Latest 12-week confirmation: trend 0/12, activity pressure 12/12, relative leadership 0/12.
Activity pressure 0.18; No reversal markers Factors30/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Buyback Yield rank 86; Small Cap Core rank 84 SVQF18/100Value and quality alignment from the Sharemaestro SVQF framework.
Composite rank 213.0 of 260 Patient CapitalRecentActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
Recent buy signal in the last 8 weeks Sentiment50/100Weighted news tone is neutral across 11 relevant articles.
Judges Scientific plc Revenue Breakdown – LSE:JDG Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 4,250 GBP | -7.0% | 4,612 GBP | 7,760 GBP | 0.50 | -24.23 | 33.9K | Off |
| 31 Jul 2026 | 4,570 GBP | -0.4% | 4,663 GBP | 7,792 GBP | 0.81 | -19.08 | 121.0K | Off |
| 24 Jul 2026 | 4,590 GBP | 0.9% | 4,701 GBP | 7,822 GBP | 0.76 | -18.48 | 46.0K | Off |
| 17 Jul 2026 | 4,550 GBP | -6.2% | 4,736 GBP | 7,854 GBP | 0.74 | -19.03 | 49.0K | Off |
| 10 Jul 2026 | 4,850 GBP | 3.7% | 4,764 GBP | 7,886 GBP | 0.69 | -14.31 | 47.1K | Off |
| 3 Jul 2026 | 4,675 GBP | 1.1% | 4,793 GBP | 7,913 GBP | 0.50 | -20.11 | 7.3K | Off |
| 26 Jun 2026 | 4,625 GBP | 0.5% | 4,829 GBP | 7,942 GBP | 0.35 | -21.18 | 3.6K | Off |
| 19 Jun 2026 | 4,600 GBP | 3.4% | 4,858 GBP | 7,971 GBP | 0.27 | -22.01 | 2.4K | Off |
| 12 Jun 2026 | 4,450 GBP | 7.4% | 4,856 GBP | 8,001 GBP | 0.34 | -26.71 | 1.9K | Off |
| 5 Jun 2026 | 4,142 GBP | -5.8% | 4,873 GBP | 8,035 GBP | 0.46 | -32.15 | 7.8K | Off |
| 29 May 2026 | 4,399 GBP | -6.4% | 4,912 GBP | 8,071 GBP | 0.65 | -29.37 | 44.9K | Off |
| 22 May 2026 | 4,699 GBP | -7.1% | 4,955 GBP | 8,104 GBP | 0.68 | -26.15 | 111.1K | Off |
| 15 May 2026 | 5,059 GBP | 2.2% | 4,998 GBP | 8,134 GBP | 0.47 | -19.57 | 52.8K | Off |
| 8 May 2026 | 4,949 GBP | 6.3% | 5,023 GBP | 8,161 GBP | 0.11 | -22.74 | 77.4K | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.